1326 - 1350 of 8825 Results
Title
Year
-
OPENTitle: Nucleic Acid–Based Therapeutics for Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 52
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019OPENTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7011644Citation Count: 43
-
OPENTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7234797Citation Count: 53
-
OPENTitle: The complex role of inflammation and gliotransmitters in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 176Issue #:Start Page: 105940End Page: 105940Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105940Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105940Citation Count: 38
- Therapeutic approaches to cholinergic deficiency in Lewy body diseases2019RESTRICTEDTitle: Therapeutic approaches to cholinergic deficiency in Lewy body diseasesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 1Start Page: 41End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1676152Citation Count: 11
-
OPENTitle: Clinical Chronobiology: Circadian Rhythms in Health and DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 45Issue #: 03Start Page: 317End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1055/a-2538-3259Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12323393Citation Count: 2
-
OPENTitle: Targeting the proteostasis network in Huntington’s diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 49Issue #:Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2018.11.006Best OA location URL: https://doi.org/10.1016/j.arr.2018.11.006Citation Count: 78
-
OPENTitle: A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 11Start Page: 8129End Page: 8152Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14250Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14250Citation Count: 12
-
OPENTitle: Adapting the proteostasis capacity to sustain brain healthspanJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 6Start Page: 1545End Page: 1560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007Best OA location URL: http://www.cell.com/article/S0092867421001574/pdfCitation Count: 108
- Volitional Control of Brain Motor Activity and Its Therapeutic Potential2022RESTRICTEDTitle: Volitional Control of Brain Motor Activity and Its Therapeutic PotentialJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 8Start Page: 1187End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.007Citation Count: 14
-
OPENTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 68
-
OPENTitle: Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 164Issue #:Start Page: 105625End Page: 105625Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105625Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105625Citation Count: 7
-
OPENTitle: Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and managementJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 547End Page: 555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000955Best OA location URL: https://hal.science/hal-03298526Citation Count: 19
-
OPENTitle: Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00302Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00302/pdfCitation Count: 56
- Targeting the Dopaminergic System in Autoimmunity2019RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 72
-
OPENTitle: The Global Brain Health Survey: Development of a Multi-Language Survey of Public Views on Brain HealthJournal Name: Frontiers in Public HealthPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpubh.2020.00387Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpubh.2020.00387/pdfCitation Count: 16
- Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases2019OPENTitle: Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseasesJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1315End Page: 1324Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27728Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27728Citation Count: 45
-
OPENTitle: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s DiseaseJournal Name: JACS AuPublisher: American Chemical Society (ACS)Vol: 2Issue #: 9Start Page: 2013End Page: 2022Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/jacsau.2c00300Best OA location URL: https://doi.org/10.1021/jacsau.2c00300Citation Count: 35
- Mendel and urate: Acid test or random noise?2018RESTRICTEDTitle: Mendel and urate: Acid test or random noise?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 53Issue #:Start Page: 1End Page: 3Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.005Citation Count: 3
-
OPENTitle: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 5Start Page: 514End Page: 514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9050514Best OA location URL: https://www.mdpi.com/2227-9059/9/5/514/pdf?version=1620466923Citation Count: 6
-
OPENTitle: How Vacations Affect Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 151End Page: 153Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13597Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13597Citation Count: 4
-
OPENTitle: Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral SclerosisJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2017.00216Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2017.00216/pdfCitation Count: 24
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 82
-
OPENTitle: Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 44Issue #: 7Start Page: 722End Page: 736Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/nan.12486Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.12486Citation Count: 50
-
OPENTitle: Safety and tolerability of putaminal AADC gene therapy for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 73Issue #: 20Start Page: 1662End Page: 1669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356Best OA location URL: https://n.neurology.org/content/neurology/73/20/1662.full.pdfCitation Count: 408